IMS Health study shows increase in medication spending, up 8.5 percent between 2014 and 2015 Read More »

NACDS-backed bill passes Senate and House; next step is the President's signature. Read More »

The Phase III SIERRA clinical trial will test effectiveness of Iomab-B when used prior to bone marrow transplants. Read More »

Various states have enacted or are considering legislation limiting the circumstances under which maximum allowable cost programs (MACs) may be used, a decision that one expert says could result in increased pharmaceutical spending that in turn increases the cost of pharmaceutical coverage. Read More »

Concerns expressed to FDA about possibility of price increases and conflicting labels on generic drugs. Read More »

Industry professional Mike Kelly joins Adapt Pharma; takes over U.S. operating activities. Read More »

The online training helps health care professionals find ways to motivate patients to change health behaviors. Read More »

Trial data on Verseon's anti-coagulant drug family presented in Stockholm last week. Read More »

The pharmaceutical wholesale business was sold to 36.6, a Russian health and beauty retailer. Read More »

Dr. Vivek Murthy started his prescription drug crisis tour in Baltimore on April 5. Read More »

Potential treatment for early Alzheimer's disease to continue without modification to Phase III. Read More »

Amgen recently announced its win against Sanofi and Regeneron Pharmaceuticals. Read More »

NACDS and NCPA urge Congress to reduce TRICARE costs. Read More »

McKesson recently announced that it has been awarded a $139 million, five-year contract from the Department of Defense and the Defense Health Agency for its patient engagement and interoperable secure messaging solution, RelayHealth. Read More »

Allergan, a worldwide leader in the development of treatments design to combat infectious diseases, has released new data from its anti-infective portfolio. Read More »

TeaserHealth care benefits company Aetna has recently entered into an agreement with Abington Medical Specialists/AMS Cardiology in an effort to provide individuals with quality care at an affordable cost.HeadlineAetna enters into five-year deal with AMS CardiologyBodyHealth care benefits company Aetna has recently entered into an agreement with Abington Medical Specialists/AMS Cardiology in an effort to provide individuals with quality care at an affordable cost.Aetna is transforming health car Read More »

The American Society of Health-System Pharmacists (ASHP) second Match program concluded this week, with 4,273 individuals matched with more than 2,000 pharmacy residency programs nationwide. Read More »

The new officers for the American Pharmacists Association (APhA) 2016-17 Board of Directors have been selected. Read More »

Allergan, a worldwide leading pharmaceutical company, and Sosei Group Corp. subsidiary, Heptares Therapeutics, have announced that Allergan Pharmaceuticals International Limited, an Allergan subsidiary, and Heptares have an agreement in place that will give Allegran exclusive worldwide licensing rights to a wide variety of novel subtype-selective muscarinic receptor agonists that are currently in development. Read More »

Pfizer and IBM announced today a novel research partnership that will lead to the development of groundbreaking remote monitoring solutions focused on revolutionizing the care Parkinson’s patients receive. Read More »